SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-017123
Filing Date
2021-03-31
Accepted
2021-03-31 17:16:36
Documents
13
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lhdx-10k_20201231.htm 10-K 3872974
2 EX-4.3 lhdx-ex43_359.htm EX-4.3 50036
3 EX-23.1 lhdx-ex231_484.htm EX-23.1 3280
4 EX-31.1 lhdx-ex311_9.htm EX-31.1 19646
5 EX-31.2 lhdx-ex312_8.htm EX-31.2 19652
6 EX-32.1 lhdx-ex321_6.htm EX-32.1 9422
7 EX-32.2 lhdx-ex322_7.htm EX-32.2 9478
8 GRAPHIC gttzzq0uv40o000002.jpg GRAPHIC 419112
9 GRAPHIC gttzzq0uv40o000006.jpg GRAPHIC 163469
10 GRAPHIC gttzzq0uv40o000003.jpg GRAPHIC 124301
11 GRAPHIC gttzzq0uv40o000004.jpg GRAPHIC 418087
12 GRAPHIC gttzzq0uv40o000001.jpg GRAPHIC 601159
13 GRAPHIC gttzzq0uv40o000005.jpg GRAPHIC 285163
  Complete submission text file 0001564590-21-017123.txt   6756463
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39976 | Film No.: 21794619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances